Visen Pharmaceuticals grants 514,068 share awards under post-IPO incentive scheme

• Visen Pharmaceuticals granted 514,068 share awards to 19 senior managers and employees under its post-IPO scheme.
• Awards carry nil purchase price; shares closed at HK$ 18.9 on the grant date.
• Vesting spans multiple years, mixing time-based schedules with performance-based milestones for portions of the grant.
• Awards run for 10 years from March 21, 2025; unvested awards will be forfeited on March 21, 2035.
• Share pool under the scheme totals 2,399,500 shares; 1,559,182 shares remain available for future grants.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Visen Pharmaceuticals published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260720-12250131), on July 20, 2026, and is solely responsible for the information contained therein.